Loading…
enVVeno Medical Corporation is projected to rise to $11.51 by 2027, a +8% move from its current price of $10.70. NVNO is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/4/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 5 | $10.40 | $10.71 | $11.02 | +0.09% |
| Aug 6 | $10.29 | $10.72 | $11.17 | +0.17% |
| Aug 7 | $10.20 | $10.73 | $11.28 | +0.26% |
| Aug 8 | $10.13 | $10.74 | $11.38 | +0.35% |
| Aug 9 | $10.07 | $10.75 | $11.46 | +0.43% |
| Aug 10 | $10.02 | $10.76 | $11.54 | +0.52% |
| Aug 11 | $9.97 | $10.76 | $11.62 | +0.61% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $9.97 | $10.76 | $11.62 | +0.61% |
| Week 2 | $9.72 | $10.83 | $12.07 | +1.21% |
| Week 3 | $9.55 | $10.90 | $12.44 | +1.83% |
| Week 4 | $9.41 | $10.96 | $12.77 | +2.44% |
| Week 5 | $9.30 | $11.03 | $13.08 | +3.06% |
| Week 6 | $9.20 | $11.09 | $13.38 | +3.69% |
| Week 7 | $9.12 | $11.16 | $13.66 | +4.31% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
enVVeno Medical Corporation is a medical device company focused on bioprosthetic tissue-based solutions to enhance the standard of care in the treatment of venous disease in the United States. Its lead product is the VenoValve, a surgical replacement venous valve for the treatment of venous chronic venous insufficiency. The VenoValve is implanted into the femoral vein of the patient in an open surgical procedure via a 5-to-6-inch incision in the upper thigh.
The company also develops enVVe, a non-surgical and transcatheter-based replacement venous valve system consisting of the enVVe valve, enVVe delivery system, and delivery system accessories. The company was formerly known as Hancock Jaffe Laboratories, Inc. and changed its name to enVVeno Medical Corporation in October 2021.
enVVeno Medical Corporation was incorporated in 1999 and is based in Irvine, California.
NVNO is currently trading at $10.15 with a market cap of $6.78M and holds a rank of 5166. The near-term technical picture shows a bearish bias, while the multi-year forecast points to meaningful upside ahead. The 2026-2050 forecast outlines a path from a 2026 avg of $10.15 to a 2050 avg of $46.24, with a max of $94.11 in 2050 and a long-run bullish sentiment.
A major floor 15.8% below — a decisive break under it would weaken the trend.
The nearest floor, 8.5% below — buyers have tended to step in here.
The nearest ceiling, 6.3% above — a clean break opens room to run.
A major ceiling 21.5% above — clearing it would confirm fresh momentum.
Key NVNO support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of NVNO market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $10.54 | Buy | $10.53 | Buy |
| MA 10 | $10.45 | Buy | $10.53 | Buy |
| MA 20 | $10.69 | Buy | $10.59 | Buy |
| MA 50 | $10.66 | Buy | $10.68 | Buy |
| MA 100 | $10.80 | Sell | $12.23 | Sell |
| MA 200 | $12.66 | Sell | $23.88 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 49.87 | Neutral |
| Stoch RSI (14) | 68.28 | Neutral |
| CCI (20) | -19.26 | Neutral |
| Williams %R (14) | -46.74 | Info |
| MACD (12,26,9) | -0.01 | Sell |
| ROC (12) | -1.49 | Sell |
| Bollinger %B (20,2) | 0.44 | Neutral |
| Stochastic %K (14) | 53.26 | Neutral |
| TRIX (15) | -0.06 | Sell |
| Awesome (5,34) | -0.10 | Sell |
| Ultimate (7,14,28) | 60.28 | Neutral |
| Momentum (10) | -0.19 | Sell |
| Aroon Osc (25) | -36.00 | Sell |
| Hull MA (9) | 10.59 | Buy |
| ADX (14) | 7.28 | Neutral |
| ATR (14) | 0.25 | Info |
The 30-day technical picture is bearish, with RSI14 at 40. The stock trades around the 50-day moving average of $10.57 and below the 200-day moving average of $13.50, signaling potential near-term weakness. Support is estimated at $9.79 and resistance at $11.37, with a 30-day price range from $8.07 to $12.76.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $8.67 | $10.70 | $14.32 | 0% | Neutral | |
| $9.14 | $11.51 | $15.37 | +8% | Neutral | |
| $10.13 | $13.16 | $18.27 | +23% | Bullish | |
| $12.41 | $16.52 | $23.65 | +54% | Bullish | |
| $12.43 | $16.91 | $24.85 | +58% | Bullish | |
| $12.02 | $16.69 | $25.07 | +56% | Bullish | |
| $11.96 | $16.91 | $25.92 | +58% | Bullish | |
| $12.18 | $17.53 | $27.36 | +64% | Bullish | |
| $13.81 | $20.21 | $32.07 | +89% | Bullish | |
| $15.47 | $23.00 | $37.07 | +115% | Bullish | |
| $17.05 | $27.25 | $46.83 | +155% | Bullish | |
| $31.62 | $57.29 | $108.11 | +435% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $8.67 | $10.70 | $13.02 | +0.00% |
| September 2026 | $9.66 | $11.43 | $13.93 | +6.86% |
| October 2026 | $9.70 | $11.57 | $14.27 | +1.23% |
| November 2026 | $9.41 | $11.30 | $14.05 | -2.39% |
| December 2026 | $9.46 | $11.42 | $14.32 | +1.08% |
Click any year to see its month-by-month NVNO forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Expect NVNO to range from $8.67 to $14.32 through 2026. The $10.70 average target implies a 0% move from current prices. Price action looks broadly range-bound.
The NVNO price prediction for 2027 points to an average of $11.51 (low $9.14, high $15.37) — a potential gain of +8% on today's $10.70. A consolidation phase looks the most probable path here.
In 2028, NVNO is projected to trade between $10.13 and $18.27, averaging $13.16 — a potential gain of +23% from today's $10.70. That is up +14% on the projected 2027 average. Momentum favours further upside here.
enVVeno Medical Corporation's 2029 outlook centres on $16.52, within a $12.41 to $23.65 range. That is up +26% on the projected 2028 average. That marks a +54% change versus current levels. Buyers look set to stay in control over this stretch.
By 2030, NVNO could reach as high as $24.85, with a base case around $16.91 and support toward $12.43 — roughly +58% from $10.70. Momentum favours further upside here.
Expect NVNO to range from $12.02 to $25.07 through 2031. The $16.69 average target implies a +56% move from current prices. That is -1% versus the projected 2030 average. Buyers look set to stay in control over this stretch.
The NVNO price prediction for 2032 points to an average of $16.91 (low $11.96, high $25.92) — a potential gain of +58% on today's $10.70. Momentum favours further upside here.
In 2033, NVNO is projected to trade between $12.18 and $27.36, averaging $17.53 — a potential gain of +64% from today's $10.70. That is up +4% on the projected 2032 average. Buyers look set to stay in control over this stretch.
enVVeno Medical Corporation's 2034 outlook centres on $20.21, within a $13.81 to $32.07 range. That is up +15% on the projected 2033 average. That marks a +89% change versus current levels. Momentum favours further upside here.
By 2035, NVNO could reach as high as $37.07, with a base case around $23.00 and support toward $15.47 — roughly +115% from $10.70. Buyers look set to stay in control over this stretch.
Expect NVNO to range from $17.05 to $46.83 through 2040. The $27.25 average target implies a +155% move from current prices. That is up +18% on the projected 2035 average. Momentum favours further upside here.
The NVNO price prediction for 2050 points to an average of $57.29 (low $31.62, high $108.11) — a potential gain of +435% on today's $10.70. Buyers look set to stay in control over this stretch.
Investing $1,000 in NVNO today (≈ 93.457944 NVNO) could be worth
$5,354.15
+$4,354.15 (+435%) by 2050 · US Dollar
Based on the average projected NVNO price of $57.29 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in NVNOwould be worth at today's price.
$1,000 invested in NVNO on Jul 31, 2025 (≈ 6.197707 NVNO) would be worth
$66.32
-$933.68 (-93.4%) today · 0.07× · US Dollar
Based on a NVNO entry price of $161.35 vs. today's $10.7.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $10.39 | $1,029.84 | +3.0% |
| 1 month ago | $10.83 | $988 | -1.2% |
| 3 months ago | $10.5 | $1,019.05 | +1.9% |
| 6 months ago | $11.11 | $963.1 | -3.7% |
| 1 year ago | $161.35 | $66.32 | -93.4% |
| All time (5.0y) ago | $210 | $50.95 | -94.9% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our NVNO forecast.
Our base-case forecast reaches $21.00 around 2035.
Implied market cap at $21.00: $14.02M
Over the longer horizon, the forecast shows a cumulative bullish trend. The 2029 avg is $15.34 with a 51.1% ROI and bullish sentiment, followed by 2030 avg $15.00 with a 47.7% ROI and bullish outlook. The path continues with 2034 avg $16.47 (62.2% ROI) and 2035 avg $19.50 (92.2% ROI).
By 2040 the forecast shows avg $21.50 (111.8% ROI) and by 2050 avg $46.24 (355.6% ROI) with a bullish sentiment. The forecast indicates a progression from neutral in 2026-2028 to bullish from 2029 onward, highlighting significant long-term upside potential along with inherent uncertainty and the nature of these estimates.
Tap a question to reveal the answer.
In 2030, the forecast shows min $10.60, avg $15.00, max $22.99 with ROI 47.7% and sentiment BULLISH.
Forecasts show a bullish trend from 2029 onward, with 2029 avg $15.34 and ROI 51.1%, 2040 avg $21.50 and ROI 111.8%, and 2050 avg $46.24 with ROI 355.6%. These are estimates, not guarantees.
The 2050 max forecast is $94.11, indicating a potential path up to near that level within the forecast horizon.
Bearish sentiment with RSI14 at 40. The SMA50 is $10.57 and the SMA200 is $13.50. Support is $9.79 and resistance is $11.37. The 30-day range runs from $8.07 to $12.76.
Current price is $10.15 and market cap is $6.78M.
enVVeno Medical Corporation Community Discussion
0Share your enVVeno Medical Corporation price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.